Mork Capital Management’s AbbVie ABBV Stock Holding History

Mork Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,530	Closed	-$1.22M	–	116
2022 Q4	$1.22M	Hold	7,530	–	–	0.93%	32
2022 Q3	$1.01M	Hold	7,530	–	–	0.99%	36
2022 Q2	$1.15M	Hold	7,530	–	–	1.06%	35
2022 Q1	$1.22M	Sell	7,530 -1,770	-19%	-$257K	1.1%	29
2021 Q4	$1.26M	Hold	9,300	–	–	0.85%	46
2021 Q3	$1M	Hold	9,300	–	–	0.86%	70
2021 Q2	$1.05M	Hold	9,300	–	–	0.76%	76
2021 Q1	$1.01M	Sell	9,300 -12,900	-58%	-$1.38M	0.77%	80
2020 Q4	$2.38M	Buy	22,200 +11,100	+100%	+$1.07M	1.74%	7
2020 Q3	$972K	Hold	11,100	–	–	1.06%	38
2020 Q2	$1.09M	Hold	11,100	–	–	1.28%	26
2020 Q1	$846K	Hold	11,100	–	–	1.16%	31
2019 Q4	$983K	Buy	11,100 +2,800	+34%	+$232K	0.7%	71
2019 Q3	$628K	Hold	8,300	–	–	0.58%	91
2019 Q2	$604K	Hold	8,300	–	–	0.56%	92
2019 Q1	$669K	Hold	8,300	–	–	0.62%	91
2018 Q4	$765K	Buy	+8,300	New	+$730K	0.71%	65
2017 Q1	–	Sell	-13,400	Closed	-$842K	–	112
2016 Q4	$839K	Hold	13,400	–	–	0.59%	108
2016 Q3	$845K	Hold	13,400	–	–	0.81%	64
2016 Q2	$830K	Hold	13,400	–	–	0.83%	61
2016 Q1	$765K	Hold	13,400	–	–	0.75%	78
2015 Q4	$794K	Buy	+13,400	New	+$772K	0.76%	56

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mork Capital Management's ABBV Position: Q1 2023 in Review

Mork Capital Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 7,530 shares — an estimated $1.22M sold.

Mork Capital Management first reported a position in ABBV in Q4 2015 and held it in 22 quarters. The position peaked at $2.38M in Q4 2020. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Mork Capital Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Mork Capital Management sold 7,530 AbbVie shares in Q1 2023, an estimated $1.22M.
Mork Capital Management first reported a position in AbbVie in Q4 2015 and held it in 22 quarters.
Mork Capital Management's AbbVie position peaked at $2.38M in Q4 2020.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Mork Capital Management's 13F filing for Q1 2023, filed 12 May 2023.